A recent analysis has raised questions about the potential health impacts of glyphosate, a chemical produced by Bayer, and its possible connection to cancer through its interaction with amygdalin—a compound found in apricot seeds. Investigative discussions suggest that glyphosate might interfere with the production and efficacy of amygdalin, which some claim has anti-cancer properties.
According to scientific reasoning, glyphosate’s mechanisms—such as blocking phenylalanine synthesis and acting as a metal chelator—could reduce amygdalin levels in seeds. This compound, also known as vitamin B17 or laetrile, is theorized to release cyanide when metabolized, targeting cancer cells while sparing healthy ones. However, glyphosate’s presence may hinder this process by altering gut microbiota and enzyme activity, potentially diminishing amygdalin’s biological effects.
Historical accounts highlight the 1970s debate surrounding laetrile, a purified form of amygdalin, which was used in alternative cancer treatments. Patients reportedly experienced improvements, but regulatory actions led to its suppression. Critics argue that the focus on pharmaceutical profits may have overshadowed natural remedies like apricot seeds.
The discussion underscores ongoing controversies about dietary health, corporate influence, and the potential for natural compounds to challenge conventional medical narratives. While scientific consensus remains divided, the debate continues to spark interest in alternative approaches to cancer treatment.